Le European stock exchanges accentuate the decline during the last session of the week with Milan widens its losses: fears of military escalation in the Middle East they took over again while the Petroleum and gas continue on their course. And so they travel in negative Madrid, Frankfurt, London e Paris. The red is confirmed US futures awaiting the labor market and unemployment data that will be released in the next few hours.
READ MORE Why the dollar's reversal is pushing gold and silver higher di G. Bruschi
Investors fear a widening of the conflict in the Middle East, even if this morning they had greeted with some enthusiasm the US authorities' decision to allow India to purchase Russian oil for 30 days. An announcement that, in the immediate aftermath, slowed the rise in crude oil, with WTI holding steady in the early hours. However, this was followed by the crude has started running again (Wti +5,89% to 85,71 dollars per barrel) as well as natural gas (+4% to 52,83 euros per MWh): moreover, observers comment, the US decision on India demonstrates that the Strait of Hormuz is under the full control of Iran.
Meanwhile, the falls by 1,44% to 5.090,38 dollars an ounce. The dollar at 86,64 euro cents and 75,07 pence, while the spread between ten-year German BTPs and Bunds rises to 75,5 points, with the Italian annual yield growing by 5 points to 3,61%, the German one by 1,5 points to 2,85% and the French one by 4,2 points to 3,5%.
A Business Square they advance Amplifon (+ 3,5%) and nexi (+2%) after Thursday's slide while struggling Italgas (-1,3%). Defense and energy stocks performed very well.
And so, even looking at other European markets, they are rising Bp (+ 1,13%), Shell (+ 1,08%), Eni (+ 0,9%) and TotalEnergies (+0,34%) together with Dassault (+ 3,87%) and Leonardo (+2,12%), but, excluding these sectors, the minus sign prevails in all sectors. The ones suffering the most are the stocks of semiconductor manufacturers Be (-15,82%), Infineon (-5,89%), Asm (-5,33%) And stm (-3,67%). The automotive industry is also struggling. Volkswagen (-2,31%), Classic Ferrari for sale (–1,72%) and bmw (-1,55%). More cautious Renault (-1,05%) And Stellantis (-0,83%).
MPS still under scrutiny at Piazza Affari
Still in Milan, under the lens there is still Mps Bank after the new, potential twist reported by some newspapers: the current CEO Louis Lovaglio, who in recent days was excluded from the list for the renewal of the board of directors presented by the board itself, throws down the gauntlet, with the hypothesis that his name could lead the list of candidates promoted to the entrepreneur George Girondi. To be elected, according to The print, it relies on both the market votes and perhaps on those of the partner Dolphin, which he hopes to convince. However, there are those who consider this hypothesis impractical. In all this, MPS shares started off down by more than 2% and at mid-day they were down by -2,76%. while those of the subsidiary Mediobanca change hands at 15,85 euros (-1,84%). In just five days, Monte Paschi shares have lost almost 10 %, reaching its lowest level since last fall. On the other hand, for further clarity on governance, we will now have to wait for the shareholders' meeting on April 15th.
Prysmian, new agreements
He reversed the course instead Prysmian after winning a framework agreement with Alliander for the supply of medium and low voltage cables for the development and modernization of the Dutch electricity grid. The eight-year agreement could have a total value of up to approximately €500 million.
Edison, QatarEnergy and LNG
Positive this morning Edison who on Thursday evening announced that he had received from QatarEnergy notification of the occurrence of a force majeure event. Due to hostilities in the area, QatarEnergy has informed Edison that it will not be able to fulfill its contractual obligations relating to some deliveries of LNG cargoes scheduled at the receiving terminal starting in early April 2026. Currently, five LNG cargoes are expected to be affected. LNG deliveries scheduled for March 2026 are not affected by this communication. Edison also specifies that it does not expect any impacts on its end customers, thanks to mitigation actions and portfolio management activities underway and already implemented.
Del Vecchio Jr., the moves on Delfin announced to the FT
Leonardo Maria Del Vecchio, son of EssilorLuxottica founder Leonardo Del Vecchio, says he is close to a deal for buy the shares of two brothers in the family holding company DelfinHe states this in an interview with Financial TimesThe transaction, the newspaper recalls, would put an end to a long inheritance dispute and strengthen his influence in Italian capitalism. "We are close to agreeing on a price," Del Vecchio told the British newspaper, explaining that he is willing to buy his brothers' shares "to become Delfin's main shareholder, settle the outstanding issues surrounding my father's inheritance, and carry out his will, embodied in what he is doing." Francesco Milleri".
After Leonardo Del Vecchio's death in 2022, he says Ft, in the wake of tensions between Delfin heirs, he stopped the distribution of dividends and some strategic decisions. In his will, the entrepreneur divided Delfin's assets between his six children and his widow Nicoletta Zampillo, who received the largest share. He also made payments to his longtime collaborator Milleri, CEO of both Delfin and EssilorLuxottica.
Del Vecchio jr explained to the Financial Times to be in negotiations for triple its stake to 37,5% of Delfin, thus becoming the holding company's largest shareholder. The transaction would be structured as a leveraged buyout backed by a pool of banks.
Zealand Pharma sinks in Copenhagen
Zealand Pharma si sinks at the Copenhagen Stock Exchange, after the Disappointing results from interim trials of the anti-obesity drug developed with Swiss giant RocheThe Danish biotech's stock is suffering a drop of 33% to 247,30 Danish kroner, in what looks set to be its worst trading day ever and brings its year-to-date loss to around 46%. The stock is also the worst performer on the Stoxx Europe 600. Meanwhile, on the Zurich Stock Exchange, Roche loses 3% to 341 Swiss francs and ends up at the bottom of the SMI index (-1%)..
Zealand Pharma has announced the results of a phase 2 study on anti-obesity drug petrelintide, which did not meet investor expectations, as the weight loss of the 493 patients who participated in the trial was an average of 10,7% after 42 weeks. This is lower than those reported by other competing anti-obesity treatments, including an amylin-based drug candidate Eli Lilly, which led to weight loss of up to 20,1% in a comparable interim study. Zealand Pharma also specifies that its drug "demonstrated similar to placebo tolerability" and "at the maximum dose, no cases of vomiting or discontinuations of treatment due to gastrointestinal adverse events occurred."
(Last updated March 6, 2:45 PM)
